ethylmaleimide and gn6958

ethylmaleimide has been researched along with gn6958 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Ban, HS; Koma, Y; Nakamura, H; Uno, M	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1

Other Studies

2 other study(ies) available for ethylmaleimide and gn6958

Article	Year
Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors. Bioorganic & medicinal chemistry letters, 2012, Aug-15, Volume: 22, Issue:16 Topics: Cysteine Endopeptidases; Drug Evaluation, Preclinical; Endopeptidases; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phenylurea Compounds; Protease Inhibitors; Protein Binding; Tubulin	2012
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023

Article

Year

Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors.

Bioorganic & medicinal chemistry letters, 2012, Aug-15, Volume: 22, Issue:16

Topics: Cysteine Endopeptidases; Drug Evaluation, Preclinical; Endopeptidases; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phenylurea Compounds; Protease Inhibitors; Protein Binding; Tubulin

2012

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023